![Simon Lowry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 2 M $ in data 31/05/2026
Dr. Simon Lowry, MD, is a Chief Medical Officer, Head-Research & Development at Emergent BioSolutions, Inc. Dr. Lowry was previously employed as a Chief Executive Officer by Mysthera Therapeutics AG.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 29/04/2026 | 177.914 ( 0,34% ) | 2 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Direttore Tecnico/Scientifico/R&S | 18/11/2024 |
| Società | Posizione | Fine |
|---|---|---|
Mysthera Therapeutics
 Mysthera Therapeutics BiotechnologyHealth Technology Operates as a biotech start-up intended for developing oral therapeutics | Amministratore Delegato | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 2 |
|---|---|
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Mysthera Therapeutics
Mysthera Therapeutics BiotechnologyHealth Technology Operates as a biotech start-up intended for developing oral therapeutics | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
